All articles tagged with #healthcare costs
The No Surprises Act successfully eliminated surprise patient bills but created a lucrative arbitration system that is driving up healthcare costs. Providers are winning awards far above benchmark rates, with costs shifting to employer-sponsored plans and potentially raising premiums.
The Trump administration is distributing one-time payments to millions of Americans to offset rising healthcare costs, but experts question their effectiveness. Approximately 20 million Medicare beneficiaries will receive $90 checks in early October, while about 1 million ACA enrollees received $500 refunds starting in September. These payments are framed by the White House as cost-saving measures, yet critics argue they are insufficient against sharply increasing premiums. The timing, weeks before the November midterms, has drawn accusations of political motivation.
President Trump announced a one-time $90 payment for approximately 20 million seniors to help cover Medicare Part B premiums, funded by the Medicare Improvement Fund. The payments are set to be distributed in October via direct deposit or check, weeks before the November 3 midterm elections. Eligibility excludes those receiving Medicaid assistance, paying income-adjusted premiums, or enrolled in Medicare Advantage plans. Critics note the fund was originally designated for program operations, not direct consumer payouts, and the amount covers less than half of the standard monthly premium.
A new Kaiser Family Foundation analysis shows that the TrumpRx platform delivers mixed results for prescription drug prices. While 17 brand-name drugs cost less than the average in peer countries, 15 are more expensive, and 13 are the most costly among all compared nations. The administration claims $700 million in savings, but experts advise patients to compare prices with insurance and other discount programs.
A new analysis by the Kaiser Family Foundation (KFF) reveals that the TrumpRx website delivers mixed results for Americans seeking lower prescription drug prices. While prices for 17 brand-name drugs are lower than the average in 11 peer nations, 15 drugs cost significantly more. The site, which targets cash-paying consumers, does not guarantee the 'lowest prices in the developed world' as claimed by the administration. Notable exceptions include weight-loss drugs like Ozempic and Zepbound, which remain more expensive in the U.S. than in comparable countries. This finding contrasts with the administration's broader 'most favored nation' strategy, which has secured deals with 26 pharmaceutical companies and enrolled all 50 states in Medicaid pricing reforms.
Dementia care in the US imposes severe financial and emotional burdens on families, with monthly costs often exceeding $7,000 and lifetime expenses surpassing $400,000. While some families rely on long-term care insurance or home modifications, others deplete savings or sell homes. Caregivers report significant stress, job loss, and physical exhaustion, highlighting a systemic gap in support for aging populations.
Rising costs for weight-loss drugs are forcing US employers to cut coverage, with private-sector health benefit expenses rising 6% in 2026, more than double wage growth. While some companies restrict access to GLP-1 medications, experts argue this treats a symptom rather than the root cause of rising healthcare spending. Insurers have also tightened prior authorization requirements, creating significant hurdles for patients seeking these therapies.
A Marsh survey of more than 1,800 employers shows employer-sponsored health-insurance costs are projected to climb 8.2% in 2027, the largest rise in over two decades. Drivers include the uptake of GLP-1 weight-loss drugs, AI-based billing by medical providers, and a 2022 federal dispute-resolution process that has produced numerous medical-billing disputes and higher payouts, with hospital consolidation and advanced cancer care also pushing costs. Workers could face higher premiums or reduced coverage, and even with cost-control measures, costs would still rise—about 11% without changes to plans.
WakeMed loses two veteran executives—COO Thomas Gough to Baptist Health in Florida and Chief Physician Executive Seth Brody to UNC Health—as its proposed merger with Atrium Health moves forward amid county-level scrutiny. The Wake County Board must approve changes to WakeMed’s incorporation before the deal can close, a process delayed by concerns about patient costs. Atrium promises substantial regional investment and expanded care, while analysts note that leadership turnover is common during mergers and may not derail the transaction.
A Yahoo Life video argues that simply retiring at 67 and relying on Social Security may fall short of the lifestyle you expect. It highlights how healthcare costs, taxes, inflation, and housing can erode benefits and suggests delaying benefits and planning for longevity to close the gap.
NHS bosses warn ADHD and autism care in England is at risk of descending into chaos as demand grows, costs spiral, and unregulated private providers flood the market with wide variations in pricing for similar services; while patient choice has reduced some waits, the system faces quality and safety risks and soaring spending. A government-commissioned independent review is promised, with potential moves toward a national tariff to standardise prices.
Disney will narrow spouses’ eligibility for Disney-sponsored health plans starting in 2027 if they can obtain coverage through their own employer, with children’s coverage and vision/dental plans staying the same. The move mirrors a broader corporate response to rising healthcare costs, including an 11% projected cost rise for 2027 and higher per-employee spend driven by drug costs, affecting about 160,000 Cast Members and reflecting trends seen at other large employers.
Many patients want to join clinical trials, but recruitment is hampered by geographic, time, and cost barriers, plus limited provider referrals and difficult trial searches. While ACA-mandated coverage helps with routine trial costs, incidental expenses and out-of-network issues can block participation. Policymakers and advocacy groups are pushing to streamline rules, fund travel/childcare support, and explore decentralized trials to expand access; patients should ask about trials, use search tools, and seek navigator help to identify feasible options.
Disney will stop offering medical insurance to US employees' spouses who have access to their own employer coverage starting next year, as part of cost-cutting amid rising healthcare costs; the policy excludes spouses who are unemployed or lack such coverage and does not affect dental or vision benefits, reflecting a broader trend of employers trimming benefits to manage costs.
A Slate Pay Dirt reader explains spending a large share of her budget on GLP-1 medication not covered by insurance, which has improved weight, health, and even career prospects, while her husband views it as an unnecessary luxury. The column reframes the drug as a shared, essential investment in earning power and well-being, suggests checking employer coverage or savings programs, avoiding sketchy online pharmacies, and having a frank conversation about finances. If they can’t find a way to fund it, the marriage may face deeper issues.